Status:
COMPLETED
Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolaemia
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-centre non-interventional study of patients who are treated with any HMGCoA reductase inhibitor available in Croatia (rosuvastatin, simvastatin, atorvastatin and fluvastatin) for at le...
Eligibility Criteria
Inclusion
- patients who have been treated with one HMG-CoA reductase inhibitor for at least 6 months without changing the dose for the last 4 weeks at least.
- All patients must sign Informed consent form.
Exclusion
- Patients who have not signed the Informed consent form.
- Patients with contraindication for the treatment with HMG-CoA reductase inhibitors as per SmPC approved in Croatia.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
1868 Patients enrolled
Trial Details
Trial ID
NCT01257971
Start Date
January 1 2011
End Date
October 1 2011
Last Update
March 20 2012
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Biograd na Moru, Croatia
2
Research Site
Bjelovar, Croatia
3
Research Site
Crikvenica, Croatia
4
Research Site
Čakovec, Croatia